816 related articles for article (PubMed ID: 26712744)
1. RUCAM in Drug and Herb Induced Liver Injury: The Update.
Danan G; Teschke R
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
[TBL] [Abstract][Full Text] [Related]
2. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
3. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
4. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
5. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.
Danan G; Teschke R
Front Pharmacol; 2019; 10():853. PubMed ID: 31417407
[TBL] [Abstract][Full Text] [Related]
6. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
Teschke R; Danan G
Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
[No Abstract] [Full Text] [Related]
7. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.
Teschke R; Frenzel C; Schulze J; Eickhoff A
World J Gastroenterol; 2013 May; 19(19):2864-82. PubMed ID: 23704820
[TBL] [Abstract][Full Text] [Related]
8. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.
Frenzel C; Teschke R
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128912
[TBL] [Abstract][Full Text] [Related]
9. Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
Teschke R; Eickhoff A; Schulze J
J Clin Transl Hepatol; 2013 Sep; 1(1):59-74. PubMed ID: 26357608
[TBL] [Abstract][Full Text] [Related]
10. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
11. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.
Teschke R; Wolff A; Frenzel C; Schwarzenboeck A; Schulze J; Eickhoff A
World J Hepatol; 2014 Jan; 6(1):17-32. PubMed ID: 24653791
[TBL] [Abstract][Full Text] [Related]
12. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases.
Teschke R; Zhu Y; Jing J
J Clin Transl Hepatol; 2020 Jun; 8(2):200-214. PubMed ID: 32832401
[TBL] [Abstract][Full Text] [Related]
13. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
Shahbaz O; Mahajan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
[TBL] [Abstract][Full Text] [Related]
14. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
Teschke R
Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
[TBL] [Abstract][Full Text] [Related]
15. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
[TBL] [Abstract][Full Text] [Related]
17. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia.
Teschke R; Schulze J
Drug Saf; 2012 Dec; 35(12):1091-7. PubMed ID: 22897137
[TBL] [Abstract][Full Text] [Related]
18. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review.
Soares PF; Fernandes MTCF; Souza AS; Lopes CM; Dos Santos DAC; Oliveira DPR; Pereira MG; Prado NMBL; Gomes GSDS; Santos G; Paraná R
Ann Hepatol; 2021; 25():100539. PubMed ID: 34555512
[TBL] [Abstract][Full Text] [Related]
19. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
20. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]